Effects of human β-defensin-3 on biofilm formation‑regulating genes dltB and icaA in Staphylococcus aureus

Huang,Qiang; Fei,Jun; Yu,Hong-Jun; Gou,Yuan-Bin; Huang,Xian-Kai

doi:10.3892/mmr.2014.2309

Effects of human β-defensin-3 on biofilm formation‑regulating genes dltB and icaA in Staphylococcus aureus

Authors:
- Qiang Huang
- Jun Fei
- Hong-Jun Yu
- Yuan-Bin Gou
- Xian-Kai Huang
View Affiliations

Affiliations: Trauma Center of Daping Hospital, Third Military Medical University, Chongqing 404100, P.R. China, Rehabilitation Department, Southwest Hospital, Third Military Medical University, Chongqing 404100, P.R. China, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 404100, P.R. China
Published online on: June 10, 2014 https://doi.org/10.3892/mmr.2014.2309
Pages: 825-831

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An understanding of the regulatory mechanisms that drive Staphylococcus aureus biofilm formation may lead to the development of an effective strategy to control the increasing number of refractory clinical infections it causes. The present study examined the effects of the antimicrobial agent human β‑defensin 3 (hBD‑3) and the antibiotics vancomycin and clindamycin on the expression of the S. aureus biofilm formation‑regulating genes, icaA and dltB, during bacterial adhesion and biofilm formation. Transcription (mRNA) levels of dlt and ica genes were measured using quantitative polymerase chain reaction, and slimes of S. aureus biofilm were examined with confocal scanning laser microscopy during S. aureus adhesion and biofilm formation. Although hBD‑3, vancomycin and clindamycin led to significantly attenuated biofilm formation, their treatment‑associated effects on the mRNA expression of dlt and ica were not identical. Vancomycin and clindamycin induced sustained expression of the dlt and ica genes, which may be harnessed to induce biofilm formation. However, hBD‑3 did not have a significant affect on the transcription level of dltB during either bacterial adhesion or biofilm formation. Therefore, the mechanism of hBD‑3 that regulated the suppression of biofilm formation appears to differ from the mechanisms of vancomycin and clindamycin.

View Figures

View References

1	Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM and Baddour LM: Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 45:166–173. 2007. View Article : Google Scholar : PubMed/NCBI
2	Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N and Givskov M: Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16:2–10. 2008. View Article : Google Scholar : PubMed/NCBI
3	Costerton JW, Stewart PS and Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322. 1999. View Article : Google Scholar : PubMed/NCBI
4	Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA and Miller SI: Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 436:1171–1175. 2005. View Article : Google Scholar : PubMed/NCBI
5	Debabov DV, Heaton MP, Zhang Q, Stewart KD, Lambalot RH and Neuhaus FC: The D-Alanyl carrier protein in Lactobacillus casei: cloning, sequencing, and expression of dltC. J Bacteriol. 178:3869–3876. 1996.PubMed/NCBI
6	Neuhaus FC, Heaton MP, Debabov DV and Zhang Q: The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. Microb Drug Resist. 2:77–84. 1996. View Article : Google Scholar : PubMed/NCBI
7	Neuhaus FC and Baddiley J: A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev. 67:686–723. 2003. View Article : Google Scholar : PubMed/NCBI
8	Gross M, Cramton SE, Götz F and Peschel A: Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun. 69:3423–3426. 2001. View Article : Google Scholar : PubMed/NCBI
9	Caiazza NC and O’Toole GA: Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J Bacteriol. 185:3214–3217. 2003. View Article : Google Scholar : PubMed/NCBI
10	Frees D, Chastanet A, Qazi S, Sørensen K, Hill P, Msadek T and Ingmer H: Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol Microbiol. 54:1445–1462. 2004. View Article : Google Scholar : PubMed/NCBI
11	Götz F: Staphylococcus and biofilms. Mol Microbiol. 43:1367–1378. 2002.
12	Pratten J, Foster SJ, Chan PF, Wilson M and Nair SP: Staphylococcus aureus accessory regulators: expression within biofilms and effect on adhesion. Microbes Infect. 3:633–637. 2001. View Article : Google Scholar
13	Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, Penadés JR and Lasa I: SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol. 48:1075–1087. 2003. View Article : Google Scholar : PubMed/NCBI
14	Vuong C, Saenz HL, Götz F and Otto M: Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis. 182:1688–1693. 2000. View Article : Google Scholar : PubMed/NCBI
15	Cramton SE, Gerke C, Schnell NF, Nichols WW and Götz F: The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 67:5427–5433. 1999.PubMed/NCBI
16	Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J and Laufs R: Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun. 62:3244–3253. 1994.PubMed/NCBI
17	Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H and Laufs R: The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol. 178:175–183. 1996.PubMed/NCBI
18	Mack D, Riedewald J, Rohde H, Magnus T, Feucht HH, Elsner HA, Laufs R and Rupp ME: Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect Immun. 67:1004–1008. 1999.PubMed/NCBI
19	McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA and Pier GB: The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 66:4711–4720. 1998.
20	O’Gara JP: ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett. 270:179–188. 2007.PubMed/NCBI
21	Warnke PH, Springer IN, Russo PA, Wiltfang J, Essig H, Kosmahl M, Sherry E and Acil Y: Innate immunity in human bone. Bone. 38:400–408. 2006. View Article : Google Scholar : PubMed/NCBI
22	Harder J, Bartels J, Christophers E and Schroder JM: Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 276:5707–5713. 2001. View Article : Google Scholar : PubMed/NCBI
23	Joly S, Maze C, McCray PB Jr and Guthmiller JM: Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol. 42:1024–1029. 2004. View Article : Google Scholar : PubMed/NCBI
24	Maisetta G, Batoni G, Esin S, Florio W, Bottai D, Favilli F and Campa M: In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother. 50:806–809. 2006. View Article : Google Scholar : PubMed/NCBI
25	Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schröder J and Podschun R: Burkholderia is highly resistant to human beta-defensin 3. Antimicrob Agents Chemother. 47:1739–1741. 2003. View Article : Google Scholar : PubMed/NCBI
26	Maisetta G, Batoni G, Esin S, Luperini F, Pardini M, Bottai D, Florio W, Giuca MR, Gabriele M and Campa M: Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother. 47:3349–3351. 2003. View Article : Google Scholar : PubMed/NCBI
27	Brogden KA: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 3:238–250. 2005. View Article : Google Scholar : PubMed/NCBI
28	van der Plas MJ, Jukema GN, Wai SW, Dogterom-Ballering HC, Lagendijk EL, van Gulpen C, van Dissel JT, Bloemberg GV and Nibbering PH: Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 61:117–122. 2008.PubMed/NCBI
29	Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE and Otto M: The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol. 66:1136–1147. 2007. View Article : Google Scholar : PubMed/NCBI
30	Neut D, Hendriks JG, van Horn JR, van der Mei HC and Busscher HJ: Pseudomonas aeruginosa biofilm formation and slime excretion on antibiotic-loaded bone cement. Acta Orthop. 76:109–114. 2005. View Article : Google Scholar
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
32	Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM and Donlan RM: Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother. 54:397–404. 2010. View Article : Google Scholar : PubMed/NCBI
33	Peschel A, Otto M, Jack RW, Kalbacher H, Jung G and Götz F: Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem. 274:8405–8410. 1999.PubMed/NCBI
34	Koprivnjak T, Mlakar V, Swanson L, Fournier B, Peschel A and Weiss JP: Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J Bacteriol. 188:3622–3630. 2006. View Article : Google Scholar : PubMed/NCBI
35	Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE and Otto M: Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci USA. 104:9469–9474. 2007. View Article : Google Scholar : PubMed/NCBI
36	Bera A, Biswas R, Herbert S, Kulauzovic E, Weidenmaier C, Peschel A and Götz F: Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 189:280–283. 2007. View Article : Google Scholar : PubMed/NCBI
37	Kraus D and Peschel A: Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol. 3:437–451. 2008. View Article : Google Scholar
38	Herbert S, Bera A, Nerz C, Kraus D, Peschel A, Goerke C, Meehl M, Cheung A and Götz F: Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PloS Pathog. 3:e1022007. View Article : Google Scholar : PubMed/NCBI
39	Kuroda M, Kuwahara-Arai K and Hiramatsu K: Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun. 269:485–490. 2000. View Article : Google Scholar : PubMed/NCBI
40	Cui L, Lian JQ, Neoh HM, Reyes E and Hiramatsu K: DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 49:3404–3413. 2005. View Article : Google Scholar : PubMed/NCBI